Fibrosis attached to the tail of a levonorgestrel intra-uterine system

被引：0
|
作者：
Ortayli, N [1 ]
Say, L [1 ]
机构：
[1] Sch Med, Woman & Child Hlth Training & Res Unit, Istanbul, Turkey
来源：
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE | 2001年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
D669 [社会生活与社会问题]; C913 [社会生活与社会问题];
学科分类号：
1204 ;
摘要：
引用
收藏
页码：177 / +
页数：2
相关论文
共 50 条
  • [1] Amenorrhoea despite displaced levonorgestrel intra-uterine system
    Bobrow, C
    Cooling, H
    Bisson, D
    [J]. BRITISH JOURNAL OF FAMILY PLANNING, 2000, 26 (02): : 105 - 106
  • [2] Modern management of abnormal uterine bleeding - the levonorgestrel intra-uterine system
    Mansour, Diana
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2007, 21 (06) : 1007 - 1021
  • [3] The levonorgestrel intra-uterine system: Therapeutic application in family planning
    Dolan, LM
    Mulholland, M
    Price, J
    [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2001, 27 (01): : 19 - 21
  • [4] Clinical outcome of Levonorgestrel Intra-Uterine system in idiopathic menorrhagia
    Chattopdhyay, B.
    Nigam, A.
    Goswami, S.
    Chakravarty, P. S.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2011, 15 (07) : 764 - 768
  • [5] The non-contraceptive benefits of an intra-uterine system for levonorgestrel
    Brun, J. -L.
    Randriambelomanana, J.
    Quiboeuf, E.
    Dallay, D.
    [J]. JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2009, 38 (03): : F89 - F92
  • [6] Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia
    Haoula, Zeina J.
    Walker, Kate F.
    Powell, Martin C.
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 159 (01) : 176 - 179
  • [7] Treatment of menorrhagia with two levonorgestrel intra-uterine systems in congenital uterine anomalies
    Ullal, A.
    Ullal, H.
    Roberts, M.
    [J]. GYNECOLOGICAL SURGERY, 2008, 5 (01) : 55 - 56
  • [8] Levonorgestrel-releasing intra-uterine systems as female contraceptives
    Grandi, Giovanni
    Farulla, Antonino
    Sileo, Filomena Giulia
    Facchinetti, Fabio
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (07) : 677 - 686
  • [9] Use of anxiolytic, hypnotic, and antidepressant drugs after dispensation of a levonorgestrel 52 mg intra-uterine system compared to a 19.5 mg intra-uterine system: A nationwide matched-cohort study
    Roland, Noemie
    Baricault, Berangere
    Botton, Jeremie
    Duranteau, Lise
    Dray-Spira, Rosemary
    Weill, Alain
    Zureik, Mahmoud
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 106 - 107
  • [10] Response to "Plasma concentrations of levonorgestrel in patients with an intra-uterine progestogen delivery system: Do they have any significance?"
    Wildemeersch, Dirk A.
    [J]. MATURITAS, 2006, 55 (01) : 96 - 97
12345